Traduction de «for primary prevention » (Français → Néerlandais) :

TERMINOLOGIE

prévention de la violence
preventie van geweld

prévention de la propagation d'une infection
voorkomen van infectieverspreiding

prévention de l'ulcère du pied diabétique
preventie van diabetische voetulcus

prévention d'une rechute
terugvalpreventie

évaluation des connaissances concernant la prévention des chutes
evalueren van kennis over valpreventie

enseignement sur la prévention d'abus
educatie over preventie van misbruik

prévention d'une escarre de décubitus
decubituspreventie

prévention des chutes
valpreventie

prévention | prévention
preventie | voorkoming

prophylaxie | méthode de protection ou de prévention
profylaxe | voorbehoeding

TRADUCTIONS EN CONTEXTE

For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several
For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several randomized trials.1 Effective strategies for the secondary prevention of stroke include

° American College of Physicians ° Primary Care - Clinical Practice Guidelines ° U.S. Preventive Services Task Force Guide to Clinical Preventive Services ° National Guideline Clearinghouse ° AHRQ (Agency for Healthcare Research and Quality) ° Evidence-Based Clinical Practice Guidelines (US) - Pédiatrie
° American College of Physicians ° Primary Care - Clinical Practice Guidelines ° U.S. Preventive Services Task Force Guide to Clinical Preventive Services ° AHRQ [Agency for Healthcare Research and Quality]

Menopausal hormone therapy for the primary prevention of chronic conditions : a systematic review to update the U.S. preventive services task force recommendations.
Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. preventive services task force recommendations.

Dans l’étude JPAD (Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes), une étude randomisée ouverte, ayant inclus des patients diabétiques de type 2 sans antécédents d’affection vasculaire, l’administration d’acide acétylsalicylique (81 ou 100 mg p.j) n’a pas non plus diminué le risque cardio-vasculaire, ni la mortalité [ JAMA 2008; 300: 2134-41 avec un éditorial : 2180-1 ].
In de JPAD-studie (Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes), een gerandomiseerde open studie bij patiënten met type 2-diabetes zonder antecedenten van een vasculaire aandoening, werd met acetylsalicylzuur (81 of 100 mg p.d) evenmin een daling van het cardiovasculaire risico of van de mortaliteit gezien [ JAMA 2008; 300: 2134-41 met editoriaal : 2180-1 ].

Dans l’étude JUPITER (« Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin »), l’effet de la rosuvastatine sur l’incidence des événements majeurs de maladie cardiovasculaire athérosclérotique a été évalué chez 17 802 hommes (≥ 50 ans) et femmes (≥ 60 ans).
In de JUPITER studie (“Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluation Rosuvastatin”), werd het effect van rosuvastatine op de prevalentie van majeure atherosclerotische cardiovasculaire incidenten bestudeerd bij 17.802 mannen (≥ 50 jaar) en vrouwen (≥ 60 jaar).

27. Lee IM, Cook NR, Gaziano JM et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study.
27.Lee IM, Cook NR, Gaziano JM et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study.

Analyse de: Tonelli M, Lloyd A, Clement F et al. Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis.
Bespreking van: Tonelli M, Lloyd A, Clement F et al. Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis.

Analyse de: Bjelakovic G, Nikolova D, Gluud LL et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.
Bespreking van: Bjelakovic G, Nikolova D, Gluud LL et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.

Discussion de: Ray KK, Seshasai SRK, Erqou S et al. Statins and all-cause mortality in high-risk primary prevention.
Kaess BM, Vasan RS. Statins are not associated with a decrease in all cause mortality in a high-risk primary prevention setting.

Discussion de: Taylor F, Ward K, Moore THM et al. Statins for the primary prevention of cardiovascular disease.
Bespreking van: Taylor F, Ward K, Moore THM et al. Statins for the primary prevention of cardiovascular disease.